|
|
 |
|
Viewing report
|
|
|
|
Germany Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
Global Markets Direct, Sep 2008, Pages: 155
1 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 14
2.1 What Is This Report About? 14
2.2 Definitions 14
2.2.1 Drug delivery devices 14
3 Healthcare Sector Review 16
3.1 Healthcare Sector 16
3.2 Healthcare Expenditure 16
3.3 Healthcare Infrastructure 20
3.3.1 Healthcare Personnel Data 20
3.3.2 Healthcare Facilities Data 22
3.4 Healthcare Policy 27
4 Drug Delivery Devices in Germany 28
4.1 Drug Delivery Devices Overall Revenues (2000-2012) 28
4.2 Drug Delivery Devices Overall Volume (2000-2012) 34
4.3 Drug Delivery Devices Company Shares (2005-2006) 37
5 Inhalation Systems in Germany 38
5.1 Inhalation Systems Overall Revenues (2000-2012) 38
5.1.1 Metered Dose Inhaler Devices Overall Revenues (2000-2012) 42
5.1.2 Dry Powder Inhaler Devices Overall Revenues (2000-2012) 44
5.2 Inhalation Systems Overall Volume (2000-2012) 46
5.2.1 Metered Dose Inhaler Devices Overall Volume (2000-2012) 48
5.2.2 Dry Powder Inhaler Devices Overall Volume (2000-2012) 50
5.3 Inhalation Systems Average Price (2000-2012) 52
5.3.1 Metered Dose Inhaler Devices Average Price (2000-2012) 52
5.3.2 Dry Powder Inhaler Devices Average Price (2000-2012) 54
5.4 Inhalation Systems Distribution Share (2005-2006) 56
5.5 Inhalation Systems Company Share (2005-2006) 57
6 Infusion Systems in Germany 58
6.1 Infusion Systems Overall Revenues (2000-2012) 58
6.1.1 Infusion Disposable Sets Overall Revenue (2000-2012) 62
6.1.2 Syringe Pumps Overall Revenue (2000-2012) 64
6.1.3 Infusion Pumps Overall Revenues (2000-2012) 66
6.2 Infusion Systems Overall Volume (2000-2012) 68
6.2.1 Infusion Pumps Overall Volume (2000-2012) 69
6.2.2 Syringe Pumps Overall Volume (2000-2012) 71
6.2.3 Infusion Pumps Overall Volume (2000-2012) 73
6.3 Infusion Systems Average Price (2000-2012) 75
6.3.1 Infusion Pumps Average Price (2000-2012) 75
6.3.2 Syringe Pumps Average Price (2000-2012) 77
6.3.3 Infusion Disposable Sets Average Price (2000-2012) 79
6.4 Infusion Systems Distribution Share (2005-2006) 81
6.5 Infusion Systems Company Share (2005-2006) 82
7 Needle Free Injections in Germany 83
7.1 Needle Free Injections Overall Revenue (2000-2012) 83
7.2 Needle Free Injections Overall Volume (2000-2012) 85
7.3 Needle Free Injections Average Price (2000-2012) 87
7.4 Needle Free Injections Distribution Share (2005-2006) 89
7.5 Needle Free Injections Company Share (2005-2006) 90
8 AstraZeneca PLC Company Profile 91
8.1 Company Overview 91
8.2 Business Overview 91
8.2.1 Products 93
8.2.2 History 94
8.3 Locations And Subsidiaries 94
8.4 Other Locations & Subsidiaries 94
9 3M Company Profile 96
9.1 Company Overview 96
9.2 Business Overview 96
9.2.1 Consumer and Office 96
9.2.2 Display and Graphics 96
9.2.3 Electro and Communications 97
9.2.4 Health Care 97
9.2.5 Industrial and Transportation 98
9.2.6 Safety, Security and Protection Services 99
9.2.7 Products 99
9.3 Value Chain Analysis 101
9.3.1 Manufacturing 102
9.3.2 Product Development 102
9.3.3 Sales and Marketing 102
9.4 SWOT Analysis 103
9.4.1 3M Company Strengths 103
3M Company Weaknesses 104
3M Company Opportunities 104
3M Company Threats 105
9.5 Financial and Operational Review 106
9.6 Locations And Subsidiaries 107
10 GlaxoSmithKline plc Company Profile 109
10.1 Company Overview 109
10.2 Business Overview 109
10.2.1 Products 110
10.2.2 History 110
10.3 Locations And Subsidiaries 113
10.4 Other Locations & Subsidiaries 113
11 Baxter International Company Profile 115
11.1 Company Overview 115
11.2 Business Overview 115
11.2.1 BioScience 115
11.2.2 Medication Delivery 115
11.2.3 Renal 116
11.2.4 Products 116
11.2.5 History 117
11.3 Value Chain Analysis 120
11.3.1 Manufacturing 120
11.3.2 Product Development 120
11.3.3 Sales and Marketing 121
11.4 SWOT Analysis 122
11.4.1 Baxter International Inc. Strengths 122
11.4.2 Baxter International Inc. Weaknesses 123
11.4.3 Baxter International Inc. Opportunities 123
11.4.4 Baxter International Inc. Threats 124
11.5 Financial and Operational Review 125
11.6 Locations And Subsidiaries 127
11.7 Other Locations & Subsidiaries 127
11.8 Baxter International Inc. Pipeline Products 129
11.8.1 Next-Generation Home Hemodialysis Machine 129
12 Novartis AG Company Profile 131
12.1 Company Overview 131
12.2 Business Overview 131
12.2.1 Major Products and Services 131
12.3 Locations And Subsidiaries 132
12.4 Other Locations & Subsidiaries 132
13 Regulation System 134
13.1 Regulation System 134
13.2 Medical Equipment Approval Process 134
13.2.1 Classification of Medical Devices 134
13.3 Conformity Assessment Process 143
13.3.1 Class I devices 143
13.3.2 Class IIa devices 144
13.3.3 Class IIb devices 145
13.3.4 Class III devices 146
13.4 Post Market Surveillance 147
14 Pricing and Reimbursement 148
14.1 SHI 148
14.1.1 Private Health Insurance 148
14.1.2 Diagnosis Related Groups (DRG) 148
15 Distribution Structure 149
16 Appendix 150
16.1 Global Markets Direct Research Methodology 150
16.2 Coverage 151
16.3 Secondary Research 151
16.4 Primary Research 152
16.5 Models 152
16.6 Forecasts 153
16.7 Expert Panels 153
16.8 Currency Conversion 154
16.9 Contact Us 155
16.10 Disclaimer 155
Executive Summary
1.1 List of Tables
Table 1: Healthcare Personnel by Region in Germany, 2004 20
Table 2: Doctors by Specialty in Germany, 2000-2004 21
Table 3: Hospitals by Region in Germany, 2004 22
Table 4: Hospital Beds by Region in Germany, 2004 23
Table 5: Rehabilitation Centers by Region in Germany, 2004 24
Table 6: Rehabilitation Center Beds by Region in Germany, 2004 25
Table 7: Discharges by Diagnosis in Germany, 2004 26
Table 8: Drug Delivery Devices, Germany, Overall Revenues ($ mn), 2000-2012 28
Table 9: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007 29
Table 10: Drug Delivery Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 30
Table 11: Drug Delivery Devices, Germany, Category Revenues ($ mn), 2000-2012 31
Table 12: Drug Delivery Devices, Germany, Category Revenues ($ mn), Historic, 2000-2007 32
Table 13: Drug Delivery Devices, Germany, Category Revenues ($ mn), Forecast, 2007-2012 33
Table 14: Drug Delivery Devices, Germany, Category Volume (Units), 2000-2012 34
Table 15: Drug Delivery Devices, Germany, Category Volume (Units), Historic, 2000-2007 35
Table 16: Drug Delivery Devices, Germany, Category Volume (Units), Forecast, 2007-2012 36
Table 17: Drug Delivery Devices, Germany, Company Share by Revenue ($ mn), 2005-2006 37
Table 18: Inhalation Systems, Germany, Overall Revenues ($ mn), Historic, 2000-2007 38
Table 19: Inhalation Systems, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 39
Table 20: Inhalation Systems, Germany, Revenue by Segment ($ mn), Historic, 2000-2007 40
Table 21: Inhalation Systems, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012 41
Table 22: Metered Dose Inhaler Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007 42
Table 23: Metered Dose Inhaler Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 43
Table 24: Dry Powder Inhaler Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007 44
Table 25: Dry Powder Inhaler Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 45
Table 26: Inhalation Systems, Germany, Overall Volume (Units), Historic, 2000-2007 46
Table 27: Inhalation Systems, Germany, Overall Volume (Units), Forecast, 2007-2012 47
Table 28: Metered Dose Inhaler Devices, Germany, Overall Volume (Units), Historic, 2000-2007 48
Table 29: Metered Dose Inhaler Devices, Germany, Overall Volume (Units), Forecast, 2007-2012 49
Table 30: Dry Powder Inhaler Devices, Germany, Overall Volume (Units), Historic, 2000-2007 50
Table 31: Dry Powder Inhaler Devices, Germany, Overall Volume (Units), Forecast, 2007-2012 51
Table 32: Metered Dose Inhaler Devices, Germany, Average Price ($), Historic, 2000-2007 52
Table 33: Metered Dose Inhaler Devices, Germany, Average Price ($), Forecast, 2007-2012 53
Table 34: Dry Powder Inhaler Devices, Germany, Average Price ($), Historic, 2000-2007 54
Table 35: Dry Powder Inhaler Devices, Germany, Average Price ($), Forecast, 2007-2012 55
Table 36: Inhalation Systems, Germany, Distribution Share by Revenue ($ mn), 2005-2006 56
Table 37: Inhalation Systems, Germany, Company Share by Revenue ($ mn), 2005-2006 57
Table 38: Infusion Systems, Germany, Overall Revenues ($ mn), Historic, 2000-2007 58
Table 39: Infusion Systems, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 59
Table 40: Infusion Systems, Germany, Revenue by Segment ($ mn), Historic, 2000-2007 60
Table 41: Infusion Systems, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012 61
Table 42: Infusion Disposable Sets, Germany, Overall Revenues ($ mn), Historic, 2000-2007 62
Table 43: Infusion Disposable Sets, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 63
Table 44: Syringe Pumps, Germany, Overall Revenues ($ mn), Historic, 2000-2007 64
Table 45: Syringe Pumps, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 65
Table 46: Infusion Pumps, Germany, Overall Revenues ($ mn), Historic, 2000-2007 66
Table 47: Infusion Pumps, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 67
Table 48: Infusion Systems, Germany, Overall Volume (Units), Historic, 2000-2007 68
Table 49: Infusion Systems, Germany, Overall Volume (Units), Forecast, 2007-2012 68
Table 50: Infusion Disposable Sets, Germany, Overall Volume (Units), Historic, 2000-2007 69
Table 51: Infusion Disposable Sets, Germany, Overall Volume (Units), Forecast, 2007-2012 70
Table 52: Syringe Pumps, Germany, Overall Volume (Units), Historic, 2000-2007 71
Table 53: Syringe Pumps, Germany, Overall Volume (Units), Forecast, 2007-2012 72
Table 54: Infusion Pumps, Germany, Overall Volume (Units), Historic, 2000-2007 73
Table 55: Infusion Pumps, Germany, Overall Volume (Units), Forecast, 2007-2012 74
Table 56: Infusion Pumps, Germany, Average Price ($), Historic, 2000-2007 75
Table 57: Infusion Pumps, Germany, Average Price ($), Forecast, 2007-2012 76
Table 58: Syringe Pumps, Germany, Average Price ($), Historic, 2000-2007 77
Table 59: Syringe Pumps, Germany, Average Price ($), Forecast, 2007-2012 78
Table 60: Infusion Disposable Sets, Germany, Average Price ($), Historic, 2000-2007 79
Table 61: Infusion Disposable Sets, Germany, Average Price ($), Forecast, 2007-2012 80
Table 62: Infusion Systems, Germany, Distribution Share by Revenue ($ mn), 2005-2006 81
Table 63: Infusion Systems, Germany, Company Share by Revenue ($ mn), 2005-2006 82
Table 64: Needle Free Injections, Germany, Overall Revenues ($ mn), Historic, 2000-2007 83
Table 65: Needle Free Injections, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 84
Table 66: Needle Free Injections, Germany, Overall Volume (Units), Historic, 2000-2007 85
Table 67: Needle Free Injections, Germany, Overall Volume (Units), Forecast, 2007-2012 86
Table 68: Needle Free Injections, Germany, Average Price ($), Historic, 2000-2007 87
Table 69: Needle Free Injections, Germany, Average Price ($), Forecast, 2007-2012 88
Table 70: Needle Free Injections, Germany, Distribution Share by Revenue ($ mn), 2005-2006 89
Table 71: Needle Free Injections, Germany, Company Share by Revenue ($ mn), 2005-2006 90
Table 72: AstraZeneca PLC, Subsidiaries 94
Table 73: 3M Company, SWOT Analysis, 2006 103
Table 74: 3M Company, Financial Statements, USD Million, 2002-2006 106
Table 75: 3M Company, Financial and Operational Overview, USD Million, 2002-2006 107
Table 76: 3M Company, Subsidiaries 108
Table 77: GlaxoSmithKline plc, Subsidiaries 113
Table 78: Baxter International Inc., SWOT Analysis, 2006 122
Table 79: Baxter International Inc., Financial Statements, USD Million, 2002-2006 125
Table 80: Baxter International Inc., Financial Ratios, USD Million, 2002-2006 126
Table 81: Baxter International Inc., Other Locations 127
Table 82: Baxter International Inc., Subsidiaries 128
Table 83: Novartis Medical Nutrition, Other Locations 132
Table 84: Currency Conversion from USD to Local Currency at 2007 Constant Rate 154
Customers who bought this item also bought
Germany Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Germany Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
Germany Medical Equipment Market Analysis and Forecasts to 2015
European Insulin Delivery Devices Market
Global Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Asia-Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015
South Africa Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
Netherlands Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
North America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
US Insulin Delivery Devices: Patient Acceptance Drives Demand
Egypt Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
|
|
|
